Britannica Sources used in this answer

How do receptors recognize hormones and neurotransmitters?

Created from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.

Gleevec; imatinib — drug Docking of the anticancer drug Gleevec (imatinib) in the abl domain of the bcr-abl tyrosine kinase. Abnormalities in bcr-abl stimulate the continuous proliferation of bone marrow stem cells, causing an increase in myelogenous cells (granulocytes and macrophages) in the body and leading to chronic myelogenous leukemia (CML).

Receptors are specialized protein molecules that recognize and respond to endogenous chemical messengers, such as hormones and neurotransmitters. This recognition process is primarily based on the principle of molecular specificity, often compared to a "key fitting into a lock," where a ligand with a particular shape binds into a corresponding "pocket" within the receptor molecule.12

The binding process involves two key characteristics:
* Affinity: The tendency of a chemical messenger to bind to a specific receptor.1
* Efficacy: The ability of the resulting drug-receptor complex to produce a physiological response.1

Most receptors are embedded in the cell membrane with their binding regions facing the exterior, allowing them to detect signals without the messenger needing to enter the cell. Upon binding, the receptor undergoes a conformational change that triggers intracellular signaling, such as the activation of ion channels or the production of second messengers. In contrast, receptors for steroid hormones are located inside the cell, requiring the hormone to cross the membrane to initiate a response.123